Dr. Nabeel Samir Koro, MD

Dr. Koro practices at Methodist Mansfield Ambulatory Surgery Center in Mansfield, Texas.

Dr. Koro's NPI, 1467609362, was assigned on August 21, 2008. Dr. Koro graduated from University of Jordan Faculty of Medicine in 2006. Dr. Koro holds Texas license R6813.

Dr. Koro's primary practice is Methodist Mansfield Ambulatory Surgery Center, at 252 Matlock Road Suite 430, Mansfield, TX 76063. The practice phone is (682) 242-6006.

Dr. Koro's primary practice is Methodist Mansfield Ambulatory Surgery Center in Mansfield, Texas. Dr. Koro is also affiliated with Methodist Mansfield Medical Center. The medical group on file is Methodist Medical Group. Dmand AI also links Dr. Koro to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Koro practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Koro's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Koro is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Koro's licenses on file in 4 states: Texas, California, South Carolina and Missouri.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Koro treats.

CMS data shows 1,435 Medicare services from Dr. Koro across 15 procedure codes in 2024, for 437 Medicare patients. Medicare paid $120,028 for them.

CMS counts 437 Medicare patients who saw Dr. Koro in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Koro's median patient age at 67, with 62% women.

In 2024, Dr. Koro wrote 2,722 Medicare Part D claims for 790 patients. 73% of them were for generic drugs. CMS names the drug for 2,583 of them, across 35 drugs with 11 or more claims each, at $815,455 in total drug cost. In 2023, CMS named 2,375 claims across 32 drugs.

Dr. Koro accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Koro as offering telehealth. CMS counts 322 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Koro, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Koro, published from 2015 to 2019. The most frequent topics are Bile Duct Neoplasms, Bile Ducts, Intrahepatic and Cholangiocarcinoma. Dr. Koro's most frequent co-authors are Elie Jean Chahla, MD and Pratik H. Pandit.

CMS Open Payments shows 689 general payments to Dr. Koro from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 89% of the total. Allergan Inc. paid the most, $66,680.

Dr. Koro graduated from University of Jordan Faculty of Medicine in 2006.

Dr. Koro is in network with 24 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.